MyWay COVID 19 Response
MyWay Digital Health are here to support diabetes
care delivery during the COVID outbreak.
MyWay Digital Health: COVID19
MyWay Digital Health (MWDH) are here to support diabetes care delivery during the COVID outbreak. People with diabetes are at increased risk of poor outcomes if infected by COVID-19. Routine diabetes care is being deferred and there is a huge risk of deterioration in diabetes outcomes due to lack of monitoring, education and complications screening during this period. MWDH can provide low-cost patient and clinician facing solutions to minimise the impact of COVID-19 on diabetes outcomes.
FREE Open Access eLearning Course
Understanding Type 2 diabetes – 2 day online course (28th & 29th April) – More details
MyDiabetesEducation –NHS (UK) and INTERNATIONAL rapid deployments
Low cost, locally branded full QISMET structured education AND advice platform for type 1, type 2 and gestational diabetes patients (rapid deployment in 3-5 days)– More details
Patient-facing remote monitoring and education platform; evidence based/cost saving self-management platform aligned with LTP– More details
Clinician-facing full diabetes EHR and population management system includes Guideline adherence, population health management and remote patient monitoring/secure messaging– More details
Risk stratification and patient prioritisation tool; predicting all major diabetes complications and care deterioration e.g. during COVID care deferred – More details
Understanding Type 2 Diabetes- free online course
A free online 2 day education course on “Understanding Type 2 Diabetes” will be running 28th and 29th April by the @MyDiabetesMyWay and @MyWayDigital team. This is aimed at people with type 2 diabetes and carers or family, but may also be useful for healthcare professionals. For more information…
Participants can join the course anytime during the day, complete the course materials and interact with other people with diabetes and diabetes specialist clinicians. Participants will receive certification on completion. The team will also be running live tweet chats during the early evening to answer questions.
This course is led by Dr Debbie Wake and supported by other qualified healthcare professionals from around the UK. Detailed sign up information will follow. This aims to primarily support educational needs of patients during COVID, at a time when face to face provision is difficult.
MyDiabetes Education- rapid deployment COVID19 offer
A very low cost (around 12-25 p /cents per year per person), public health advice and fully moderated education platform >200 educational resources and for people with type 1, type 2 and gestational diabetes including QISMET accredited structured education, to deliver ongoing at home support for people with diabetes; who are otherwise at very high risk of poor outcomes, and are unable to access any face to face chronic disease management care and support during COVID shut down. We can deploy in 3-5 days. Self-service for patients: requires no health care professional input.
MyDiabetesMyWay- self-management/remote care during COVID19
Full diabetes remote monitoring and self-management platform (MyDiabetesMyWay (MDMW) – https://mywaydigitalhealth.co.uk/platform/#_mdmw ) including remote data upload (e.g. glucose, activity data, weight, BP) leading to automated self-management and treatment advice for patients and health care professionals. Links to electronic health care record (where possible) to support clinic workflow and enable patient eHR/ eMR access/ clinic reminders/ medication information etc.
Available now where capacity exists for implementation. As well as being aligned with the NHS LTP this platform is ideal to form the backbone of a planned release of restrictions whilst safely caring for those with diabetes.
MyDiabetesClinical- COVID19 remote care and risk stratification
Diabetes electronic health record, decision support platform and clinical-patient remote monitoring and secure messaging platform – can includes diabetes predictive analytics platform (MyDiabetes IQ) to support risk stratification of individual patients and diabetes populations to identify those at high risk of deterioration e.g. due to acute complications/ hospitalisation. This is necessary due to reduce chronic disease care being offered during COVID/and supports allocation of limited resources (and potential face to face appointments) to those in most need.
With remote clinics and reviews now the main mode of care delivery this platform enables scarce capacity to be targeted and to remotely care for those who need less intensive support.
MyDiabetesIQ- COVID19 risk predication/patient prioritisation
Predictive analytics platform enabling prediction of acute and chronic complications of diabetes/ hospitalisation/ mortality at individual and population level, supporting risk stratification, enabling prioritisation of allocation of care resource/ face to face appointments, to reduce deterioration in outcomes and linked clinical decision support to enable evidence based- care delivery.
MyWay Digital Health also offers platforms to support i)remote communication between patients and health care professionals, ii) remote home data upload, iii) eHR linked data-driven automated advice and health record access iv) individual care recommendations for patients and clinicians, and iv) population analytics delivering KPIs and risk predictions. These systems enable patient stratification, drives improved care outcomes, self-management, system efficiencies and cost savings (proven ROI of 5:1). For more information see: www.mwdh.co.uk